David Ali

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
David Ali
Acting CEO, Executive Director / Mediland Pharm

Dr Ali is a senior executive with more than 40 years experience in medical management, business development, sales and marketing for pharmaceutical, medical device and diagnostic companies in human and animal reproduction. He has held positions with prestigious organisations including CSIRO, Bayer, AstraZeneca, Novo Nordisk and Biogen. He was a member of the Association of Regulatory and Clinical Scientists where he also served an elected board term.

Lists and Charts

Roles

2024
Acting CEO, Executive Director
Mediland Pharm
2024
Acting CEO, Executive Director
Mediland Pharm
2024
Acting CEO, Executive Director
Memphasys
Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
1535th NewPeak Metals">NewPeak Metals -54.17% -46.92%
1536th EcoGraf">EcoGraf -54.29% -3.38%
1537th Mediland Pharm">Mediland Pharm -54.35% -37.49%
1538th Memphasys">Memphasys -54.35% -37.49%
1539th Piedmont Lithium">Piedmont Lithium -54.44% 11.38%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

      Person Activity

      		 NEW ROLE: Acting CEO, Executive Director, Memphasys 01 Aug 2024
      		NEW ROLE: Acting CEO, Executive Director, Mediland Pharm 01 Aug 2024
      		NEW ROLE: Acting CEO, Executive Director, Mediland Pharm 01 Aug 2024

    Related Information

    Access to our data for David Ali is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    David Ali is linked to 3 organisations which are included in 1 list - Public Companies - non WA.

    To see the data you will need to Subscribe.

    X